Clinical Trials Directory

Trials / Completed

CompletedNCT02884609

Tolerance and Efficiency of Paracetamol Subcutaneous Injection

Tolerance and Efficiency of Paracetamol bu Subcutaneous Releasing in Patients Hospitalized Into Palliative Care

Status
Completed
Phase
Study type
Observational
Enrollment
160 (actual)
Sponsor
Centre Hospitalier Régional Metz-Thionville · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the tolerance and the efficiency of subcutaneous administration of Paracetamol for patients in palliative care.

Detailed description

Subcutaneous administration is the most commonly used way for palliative care and geriatric service. A lot of drugs are recommended with subcutaneous administration, but their use is performed out of the Marketing Authorization, and fewer data exist about this practice in literature. Paracetamol is a grade 1 analgesic not currently recommended for subcutaneous injection, because of the lack of validated references. However this kind of administration is usually performed for Paracetamol in the French palliative care services related with its advantages for patients, as analgesic or antipyretic. The assumption of the study is that the use of paracetamol subcutaneously is possible with a good tolerance for hospitalized patients in palliative care service.

Conditions

Timeline

Start date
2014-08-01
Primary completion
2018-07-01
Completion
2018-07-01
First posted
2016-08-31
Last updated
2019-04-16

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02884609. Inclusion in this directory is not an endorsement.